Tezspire 210 MG/1.91 ML pen 1.91ML
Ended Awarded
- Contract number
- SPE2DB25FQK67
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,344
Award facts
- Contract value 100% obligated
- $2,343.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on April 24, 2025, for TEZSPIRE 210 MG/1.91 ML pen auto-injectors. The delivery order, valued at $2,343.59 with a firm fixed price structure, represents a non-set-aside competitive award requiring completion by May 15, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
As a child contract under the SPE2DX IDC, this delivery order enables the supply of critical pharmaceutical products to support military healthcare programs and other federal medical systems. TEZSPIRE (tezepelumab) is a specialty biologic medication indicated for severe asthma management, reflecting AmerisourceBergen's role in delivering specialized medications across multiple therapeutic domains through its federal contracting relationship with DLA. The firm's ability to secure this competitive award demonstrates its established capability to meet federal procurement standards and supply critical healthcare commodities to the Defense Health Agency and related military health systems.
Quick answers
Who was awarded contract SPE2DB25FQK67?
SPE2DB25FQK67 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FQK67 worth?
The government has obligated $2,344 on SPE2DB25FQK67.
Is contract SPE2DB25FQK67 an order under another contract?
Yes. SPE2DB25FQK67 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQK67 competed?
The extent of competition for SPE2DB25FQK67 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award